RSS Content

Print Page Print Page        E-mail Page Email Page        RSS Feeds RSS        E-mail Alerts Email Alerts        Financial Tear Sheet Tear Sheet
Alkermes to Present at the Morgan Stanley 15th Annual Global Healthcare Conference

DUBLIN--(BUSINESS WIRE)--Sep. 5, 2017-- Alkermes plc (NASDAQ: ALKS) announced today that its Chief Financial Officer, James Frates, will participate in a fireside chat at the Morgan Stanley 15th Annual Global Healthcare Conference on Monday, Sept. 11, 2017 at 10:30 a.m. ET (3:30 p.m. BST) from the Grand Hyatt New York. The audio portion of the fireside chat may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.

Source: Alkermes plc

Alkermes plc
Molly Cameron, +1-781-609-6143
Corporate Communications